FindMyRecallSubscribe
Class I: serious health riskTerminated

Exela Pharma Sciences 8.4% Sodium Bicarbonate Injection Recall

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials,…

Exela Pharma Sciences LLC · Lenoir, NC

Risk level
Class I
Reported by FDA
Nov 2, 2022
Recall ID
D-0023-2023
Check your lot numberHow we source this data

Summary

Exela Pharma Sciences recalled 8.4% Sodium Bicarbonate Injection starting Oct 4, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0023-2023 on Nov 2, 2022. Reason: Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration. Status: Terminated.

Why it was recalled

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Product description

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.

Lot numbers, UPCs & expiration codes

Lot #: P0001497 Exp. 12/2023; P0001600 Exp. 02/2024; P0001663 Exp. 03/2024

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0023-2023
Classification
Class I
Status
Terminated
Recall initiated
Oct 4, 2022
FDA report date
Nov 2, 2022
Quantity
148,920
Recall type
Voluntary: Firm initiated
Recalling firm
Exela Pharma Sciences LLC

Original FDA data

Every field from FDA enforcement report D-0023-2023, exactly as published.

Show all FDA fields
City
Lenoir
State
NC
Status
Terminated
Country
United States
Event ID
90956
Address
1245 Blowing Rock Blvd
Code information
Lot #: P0001497 Exp. 12/2023; P0001600 Exp. 02/2024; P0001663 Exp. 03/2024
Postal code
28645-3618
Report date
Nov 2, 2022
Product type
Drugs
Recall number
D-0023-2023
Classification
Class I
Recalling firm
Exela Pharma Sciences LLC
Product quantity
148,920
Termination date
Oct 10, 2025
Reason for recall
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Voluntary / mandated
Voluntary: Firm initiated
Product description
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 4, 2022
Initial firm notification
Letter
Center classification date
Oct 27, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0023-2023, published Nov 2, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls